Mandadi Tilak 4
4 · CVS HEALTH Corp · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
- Award
Common Stock (RSU)
2025-04-01$67.98/sh+20,594$1,399,980→ 116,257 total - Award
Stock Option
2025-04-01$67.98/sh+87,336$5,937,101→ 87,336 totalExercise: $67.98From: 2026-04-02Exp: 2035-04-01→ Common Stock (87,336 underlying) - Tax Payment
Common Stock
2025-04-01$67.98/sh−995$67,640→ 43,503 total
Footnotes (3)
- [F1]Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
- [F2]Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2026.
- [F3]Option becomes exercisable in four equal annual installments, commencing on 4/1/2026.